Bioxytran, Inc.
BIXT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $12 | $20 | $55 | $43 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $2 | $2 | $2 |
| Enterprise Value | $14 | $22 | $57 | $45 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$4 | -$2 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$4 | -$2 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.017 | -0.032 | -0.021 | -0.041 |
| % Growth | 46.4% | -49.1% | 47.7% | – |
| Operating Cash Flow | -$0 | -$1 | -$2 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$1 | -$2 | -$2 |